Open access · CC-BY
via OpenAlex
Blood–brain-barriers in aging and in Alzheimer’s disease
Fernanda Marques, João Carlos Sousa, Nuno Sousa, Joana Almeida Palha
Molecular Neurodegeneration · 2013 · ▲ 274 citations
Abstract
The aging process correlates with a progressive failure in the normal cellular and organ functioning; these alterations are aggravated in Alzheimer's disease (AD). In both aging and AD there is a general decrease in the capacity of the body to eliminate toxic compounds and, simultaneously, to supply the brain with relevant growth and nutritional factors. The barriers of the brain are targets of this age related dysfunction; both the endothelial cells of the blood-brain barrier and the choroid plexus epithelial cells of the blood-cerebrospinal fluid barrier decrease their secretory capacity towards the brain and their ability to remove toxic compounds from the brain. Additionally, during normal aging and in AD, the permeability of the brain barriers increase. As such, a greater contact of the brain parenchyma with the blood content alters the highly controlled neural environment, which impacts on neural function. Of interest, the brain barriers are more than mere obstacles to the passage of molecules and cells, and therefore active players in brain homeostasis, which is still to be further recognized and investigated in the context of health and disease. Herein, we provide a review on how the brain barriers change during aging and in AD and how these processes impact on brain function.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/1750-1326-8-38
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Marques, F., Sousa, J.C., Sousa, N., & Palha, J.A. (2013). Blood–brain-barriers in aging and in Alzheimer’s disease. <em>Molecular Neurodegeneration</em>. https://doi.org/10.1186/1750-1326-8-38
Vancouver
Marques F, Sousa JC, Sousa N, Palha JA. Blood–brain-barriers in aging and in Alzheimer’s disease. Molecular Neurodegeneration. 2013. doi:10.1186/1750-1326-8-38.
BibTeX
@article{fernanda2013Bloodb,
title = {Blood–brain-barriers in aging and in Alzheimer’s disease},
author = {Fernanda Marques and João Carlos Sousa and Nuno Sousa and Joana Almeida Palha},
journal = {Molecular Neurodegeneration},
year = {2013},
doi = {10.1186/1750-1326-8-38},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Kansas Medical Center 2019
Open access · US-GOV
Enhanced Mediterranean Diet for Alzheimer's Disease Prevention
Frontiers in Aging 2022
Open access · CC-BY
The two faces of DNA oxidation in genomic and functional mosaicism during aging in human neurons
Biochemical Pharmacology 2014
Preprint · OA
Microglial dysfunction in brain aging and Alzheimer's disease
European Journal of Neuroscience 2026
Open access · OA
Mitochondria‐Associated Membranes as a Convergent Hub of Brain Aging: From Neurodegeneration to Cerebral Ischemia
Karolinska Institutet 2025
Open access · US-GOV
Walking and Thinking - Brain Activity During Complex Walking in Atypical Parkinsonian Syndromes
PLoS Medicine 2018
Open access · CC-BY